Mandate

Vinge advises Stendörren Fastigheter in connection with its listing on Nasdaq Stockholm

March 30, 2018

Vinge advises Stendörren Fastigheter AB (publ) in connection with its list change from Nasdaq First North Premier to Nasdaq Stockholm’s main market.

The prospectus was published on 29 March 2018 and the trading on Nasdaq Stockholm is expected to commence on 10 April 2018.

Stendörren is a property company that owns, develops and manages properties within the Greater Stockholm and Mälardalen area, with a primary focus on properties within the logistics, warehouses and lighter industry segments. Stendörren’s property portfolio consists of 101 properties with an underlying value of approximately 6.6 billion SEK.

Vinge’s team has primarily consisted of Jesper Schönbeck, David Andersson, Nils Fredrik Dehlin, William Kåge, Frida Ställborn, Sara Osman and Hampus Olsson.

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025